当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Tissue Engineering: Bridging the Gap between Regenerative Medicine and Biomedical Engineering

Sesiliya D

Tissue engineering is an interdisciplinary field that combines principles from regenerative medicine and biomedical engineering to create functional tissue substitutes or assist in tissue regeneration. This abstract provides an overview of tissue engineering, highlighting its key components, strategies, and applications in the field of healthcare. Tissue engineering aims to address the limitations of conventional therapies for tissue repair and regeneration by developing engineered tissue constructs that closely mimic the structure and function of native tissues. It involves the integration of three main components cells, scaffolds, and bioactive factors. Cells, including stem cells or differentiated cells, are seeded onto biocompatible scaffolds, which provide a supportive framework for cell attachment, growth, and tissue formation. Bioactive factors, such as growth factors or signaling molecules, are incorporated to guide cell behavior and promote tissue development. Various strategies are employed in tissue engineering, including scaffold-based approaches, cell-based therapies, and bioprinting techniques. Scaffold-based approaches involve the fabrication of three-dimensional (3D) structures that provide mechanical support and promote cell adhesion and proliferation. Cell-based therapies focus on the delivery of cells alone or in combination with supportive materials to initiate tissue regeneration. Bioprinting techniques utilize specialized printers to deposit cells, biomaterials, and bioactive factors layer-by-layer to create complex, functional tissue constructs. Tissue engineering has found applications in a wide range of clinical areas, including bone regeneration, cartilage repair, skin substitutes, and organ transplantation. The field continues to advance through ongoing research and development efforts, aiming to address the challenges of vascularization, innervation, and functional integration of engineered tissues. This abstract concludes by highlighting the potential of tissue engineering in revolutionizing healthcare, offering alternatives to conventional treatments and providing personalized solutions for patients. The integration of tissue engineering with other emerging technologies, such as biomaterials, bioreactors, and advanced imaging techniques, holds promise for the future of regenerative medicine, tissue repair, and organ transplantation. In summary, tissue engineering combines regenerative medicine and biomedical engineering principles to create functional tissue substitutes. With its focus on cells, scaffolds, and bioactive factors, tissue engineering offers innovative strategies for tissue repair and regeneration. Ongoing advancements in scaffold design, cell-based therapies, and bioprinting techniques contribute to the progress of tissue engineering, making it a promising field for personalized healthcare solutions.